Welcome to Synapse - connecting you with news and analysis on legal and commercial issues in the life sciences.
< Back
This month on Synapse: Outsourcing the manufacturing of drugs
For many companies conducting pre-clinical and clinical development programs it is often necessary, and usually cost-effective, to outsource manufacturing of the study drug to a Contract Manufacturing Organisation (CMO).
This outsourcing gives rise to a number of commercial and legal issues which need to be carefully managed to limit the risks to the company concerned. In this article we examine a number of the risks, the problems which can arise and the strategies which can be employed to minimise the potential exposure.
Synapse Toolkit
A legal toolkit for life sciences companies and their investors providing access to information on:
Protecting and enforcing intellectual property
Entering into commercial agreements
Topical Issues
With much interest focussing on biosimilars, lawyers from our European team discuss the difficult issue....read more
Pensions - there is no alternative
Rosalind Connor explains why auto-enrolment means that employers within the life sciences industry will be unable....read more
UK tax relief for research and development
Nikol Davies and James Stewart explain how companies engaged in R&D can benefit from enhanced corporation tax reliefs.... read more
Re-packaging of parallel imported medicinal products in Austria
Rainer Schultes explains important guidance on this issue that has come from the Austrian Supreme Court....read more
Taylor Wessing / IBIL Conference: Patent Litigation in the EU - 11 June 2013 - London
UCL IBIL and Taylor Wessing are pleased to announce a joint conference regarding the roles of experts & scientific advisors in Patent Litigation in the EU. The event will be held at: Faculty of Laws, University College London, Bentham House, Endsleigh Gardens, London WC1H 0EG .......read more
© 2013 Taylor Wessing LLP